Event
MIND THE GAP! How to Pave the Way to Access to Authorised ATMPs for Patients?
An event by the TRANSFORM MEP Interest Group
Advanced Therapies Medicinal Products (ATMPs) are highly personalised treatments with the potential to transform the lives of patients.
This meeting has brought together policy-makers (MEPs, representatives of EU institutions, national representatives), regulators (EMA), patient representatives, medical experts, scientists, researchers, industry representatives and academics to discuss recommended changes in policy and practice, and to offer solutions to unlock patients’ access to ATMPs in Europe.
Confirmed Speakers

Ondřej Knotek
MEP, Renew Europe Czechia

Dr. Alexander Natz
Secretary-General, EUCOPE

Jo De Cock
Administrateur Général Honoraire, INAMI-RIZIV

Radka Maxová
MEP, S&D, Czechia

Simone Boselli
Public Affairs Director, EURORDIS-Rare Disease Europe

Wim Goettsch
Special Advisor HTA, Dutch National Health Care Institute (ZIN)

Oswald Bentinck
Head of Market Access EMEA, Novartis Gene Therapies

TRANSFORM Alliance Members

Billy Kelleher
MEP, Renew Europe, Ireland

Alessandra Moretti
MEP, S&D, Italy